Dare Bioscience (DARE) Asset Utilization Ratio (2014 - 2026)
Dare Bioscience's (DARE) quarterly Asset Utilization Ratio came in at 0.03 in Q4 2025, up 6588.35% YoY from 0.0 in Q4 2024, and up 1347.21% on a QoQ basis from 0.0 in Q3 2025.
Dare Bioscience (DARE) Asset Utilization Ratio (2014 - 2026) Analysis & Trends
Dare Bioscience (DARE) has 9 years of Asset Utilization Ratio data on file, last reported at 0.03 in Q4 2025.
- Quarterly Asset Utilization Ratio rose 6588.35% year-over-year to 0.03 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.03 (up 6588.35% YoY) and the FY2025 annual result came in at 0.04, up 8270.01% from the prior year.
- Asset Utilization Ratio climbed to 0.03 in Q4 2025, from 0.0 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.27 in Q1 2023 to a low of 0.0 in Q3 2025.
- A 5-year average of 0.1 and a median of 0.09 in 2024 frame the typical range for Asset Utilization Ratio.
- The widest YoY moves for Asset Utilization Ratio: up 6588.35% in 2025, down 102.89% in 2025.
- Tracing DARE's Asset Utilization Ratio over 5 years: stood at 0.01 in 2021, then surged by 1629.86% to 0.21 in 2022, then slumped by 42.91% to 0.12 in 2023, then plunged by 99.6% to 0.0 in 2024, then soared by 6588.35% to 0.03 in 2025.
- The last three Asset Utilization Ratio figures came in at 0.03 (Q4 2025), 0.0 (Q3 2025), and 0.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 0.90 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.54 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.13 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.13 |
| 10 | Dare Bioscience | 11.91 Mn | -705,728.22 | -132,343.00 | 0.04 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.04 |
| Dec 31, 2025 | 0.03 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | 0.09 |
| Jun 30, 2024 | 0.16 |
| Mar 31, 2024 | 0.16 |
| Dec 31, 2023 | 0.12 |
| Sep 30, 2023 | 0.04 |
| Mar 31, 2023 | 0.27 |
| Dec 31, 2022 | 0.21 |
| Sep 30, 2022 | 0.20 |
| Jun 30, 2022 | 0.20 |
| Dec 31, 2021 | 0.01 |
| Sep 30, 2021 | 0.06 |
| Jun 30, 2021 | 0.21 |
| Jun 30, 2017 | 0.22 |
| Mar 31, 2017 | 0.24 |